Abstract
The relative benefits and risks of nanomedicine have led to global indecisiveness regarding a suitable approach for regulation of this industry, and Australia is no exception. This article proposes a meta-regulation approach for regulating nanomedicine in Australia, demonstrating how this approach enables companies to surpass their compliance requirements and improve stakeholders’ capacity to deal with the inherent uncertainty surrounding the emergent science of nanotechnology.
| Original language | English |
|---|---|
| Pages (from-to) | 133-137 |
| Journal | Alternative Law Journal |
| Volume | 44 |
| Issue number | 2 |
| Early online date | 17 Dec 2018 |
| DOIs | |
| Publication status | Published - Jun 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 4 Quality Education
Fingerprint
Dive into the research topics of 'Nanomedicine regulation in Australia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver